Droice Labs
New York
About Droice Labs
Droice Labs’ AI middlewares help biopharma companies and healthcare providers generate robust evidence (e.g. RWE) for regulatory (e.g. FDA, EMA) and coverage/reimbursement (e.g. CMS, private payers) decision-making by scalably converting messy RWD (EHR, claims, etc.) into high-quality, reliable, analysis-ready patient data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Dec 2021)
- Website: droicelabs.com
- Phone: 929-224-0049
Industries & Categories
Artificial Intelligence (AI), Health Care, Hospital, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/droice-labs-106466 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.